139 related articles for article (PubMed ID: 8029886)
21. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
[TBL] [Abstract][Full Text] [Related]
22. A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects.
Vossen AC; Tibbe GJ; van Oudenaren A; Vredendaal AE; Benner R; Savelkoul HF
Transplant Proc; 1994 Dec; 26(6):3157-8. PubMed ID: 7998101
[No Abstract] [Full Text] [Related]
23. Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats.
Otsu I; Gottschalk R; Monaco AP
Transplant Proc; 1994 Oct; 26(5):3060. PubMed ID: 7940962
[No Abstract] [Full Text] [Related]
24. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
Schorlemmer HU; Kurrle R
Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
[No Abstract] [Full Text] [Related]
25. Long-term survival and use of human skin xenografts in immunosuppressed mice.
Jánossy T; Vizler C; Krizsa J; Hunyadi J; Kiss M; Nyirati I; Dobozy A; Végh P
Transplant Proc; 1994 Jun; 26(3):1268-70. PubMed ID: 8029904
[No Abstract] [Full Text] [Related]
26. Marked prolongation of rat skin xenografts induced by intrathymic injection of xenogeneic splenocytes and a short course of rapamycin in antilymphocyte serum-treated mice.
Dono K; Wood ML; Ozato H; Otsu I; Gottschalk R; Maki T; Monaco AP
Transplantation; 1995 Apr; 59(7):929-32. PubMed ID: 7709451
[TBL] [Abstract][Full Text] [Related]
27. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
Bobbio SA; Wood ML; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
[No Abstract] [Full Text] [Related]
28. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
[No Abstract] [Full Text] [Related]
29. Donor-derived plasma transferrin facilitates the engraftment of xenogeneic (rat) bone marrow in irradiated mice.
Pierpaoli W; Lesnikov V; Lesnikova M; Arrighi S
Bone Marrow Transplant; 1996 Jul; 18(1):203-7. PubMed ID: 8832016
[TBL] [Abstract][Full Text] [Related]
30. Cardiac and skin xenograft survival in different recipient mouse strains.
Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
[TBL] [Abstract][Full Text] [Related]
31. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
[No Abstract] [Full Text] [Related]
32. Extended and expanded studies of xenograft rejection in immunodeficient animals.
Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
[No Abstract] [Full Text] [Related]
33. Experiments in cardiac xenotransplantation: fetal and neonatal exposure of graft recipients to xenogeneic cells.
Mohiuddin M; Shen Z; Rostami S; DiSesa VJ
Transplant Proc; 1994 Jun; 26(3):1306-7. PubMed ID: 8029916
[No Abstract] [Full Text] [Related]
34. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
[TBL] [Abstract][Full Text] [Related]
35. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
[TBL] [Abstract][Full Text] [Related]
36. Variations in the responses of mouse strains to rat xenografts.
Burdick JF; Jooste SV; Winn HJ
J Immunol; 1979 Aug; 123(2):954-5. PubMed ID: 379223
[No Abstract] [Full Text] [Related]
37. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
[No Abstract] [Full Text] [Related]
38. Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells.
Morita H; Sugiura K; Nagahama T; Sakakura Y; Tu W; Oda M; Inoue T; Inui H; Taketani S; Kamiyama Y; Ikehara S
Transplant Proc; 2000 Mar; 32(2):293-4. PubMed ID: 10715422
[No Abstract] [Full Text] [Related]
39. Augmentation of microchimerism with donor bone marrow infusion in hamster-to-rat heart xenograft recipients.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1999; 31(1-2):694-5. PubMed ID: 10083300
[No Abstract] [Full Text] [Related]
40. Sublethal irradiation and syngeneic bone marrow transplant prolong thyroid xenograft survival.
Moss AA; Almond PS; Chen SC; Fischel RJ; Salazar A; Matas AJ
Transplant Proc; 1992 Apr; 24(2):505. PubMed ID: 1566406
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
